Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3605 |  BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.29 USD | -2.05% | +1.66% | +4.13% | -42.95% | 216.10 M USD | ||
| 3607 |  NERV Minerva Neurosciences, Inc - Common Stock | 4.61 USD | -3.35% | -14.79% | -1.28% | +174.40% | 214.77 M USD | ||
| 3624 |  KRRO Korro Bio, Inc. - Common Stock | 14.42 USD | -0.48% | +5.26% | +33.77% | -62.93% | 207.97 M USD | ||
| 3625 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 74.35 USD | -3.23% | +3.54% | -8.19% | +931.21% | 207.15 M USD | ||
| 3632 |  ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 7.24 USD | -4.74% | +4.93% | -0.55% | -48.29% | 205.78 M USD | ||
| 3635 |  ALEC Alector, Inc. - Common Stock | 1.84 USD | -4.66% | -7.54% | +12.20% | +21.05% | 204.29 M USD | ||
| 3638 |  IMUX Immunic, Inc. - Common Stock | 14.86 USD | -3.26% | -0.54% | +19.84% | +1690.36% | 202.42 M USD | ||
| 3639 |  CRBU Caribou Biosciences, Inc. - Common Stock | 2.03 USD | +5.73% | +16.00% | +8.56% | +24.54% | 201.34 M USD | ||
| 3651 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 12.47 USD | -1.89% | +0.89% | +6.40% | -16.92% | 198.78 M USD | ||
| 3655 |  QSI Quantum-Si Incorporated - Class A Common Stock | 0.91 USD | -1.09% | -3.19% | -14.15% | -50.00% | 198.16 M USD | ||
| 3664 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.71 USD | +5.45% | +5.04% | +23.18% | +120.33% | 195.74 M USD | ||
| 3665 |  TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.90 USD | -2.17% | +21.62% | +28.57% | +38.46% | 195.30 M USD | ||
| 3668 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 1.61 USD | +10.27% | +7.33% | +123.61% | +292.68% | 194.59 M USD | ||
| 3670 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.41 USD | +1.69% | +3.88% | +22.96% | -17.47% | 194.18 M USD | ||
| 3674 |  WHWK Whitehawk Therapeutics, Inc. - Common Stock | 3.92 USD | -5.54% | -12.89% | -3.92% | +30.23% | 193.85 M USD | ||
| 3687 |  EQ Equillium, Inc. - Common Stock | 2.97 USD | +3.12% | 0.00% | +6.07% | +858.06% | 187.78 M USD | ||
| 3689 |  LENZ LENZ Therapeutics, Inc. - Common Stock | 5.96 USD | +1.02% | +4.75% | -12.09% | -81.66% | 186.87 M USD | ||
| 3690 |  MDWD MediWound Ltd. - Ordinary Shares | 14.55 USD | -2.61% | -2.02% | +2.46% | -21.52% | 186.75 M USD | ||
| 3693 |  ADAG Adagene Inc - ADS, each representing 1.25 | 3.93 USD | 0.00% | -16.38% | +19.82% | +106.84% | 186.23 M USD | ||
| 3722 |  ACOG Alpha Cognition Inc. - Common Stock | 8.15 USD | +0.62% | +4.62% | +33.61% | -25.50% | 177.46 M USD |
Noticias Biotechnology Stocks
TD Cowen reitera su recomendación de compra en Prime Medicine tras ganar arbitraje
BofA reitera su calificación de Beam Therapeutics tras fallo arbitral
¿Por qué cae hoy la acción de Beam Therapeutics?
¿Por qué las acciones de Prime Medicine se disparan hoy?
La acción de Incyte alcanza un máximo de 52 semanas en 118,77 dólares
Las acciones de Prime Medicine suben tras ganar arbitraje contra Beam
Resultados de Nurix Therapeutics: la atención se centra en el acuerdo con Roche
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |